We are live on
!
Find out more
HA
Highland Associates Portfolio holdings
AUM
$699M
1-Year Est. Return
8.2%
This Fund
S&P 500
This Quarter
Est. Return
-0.49%
1 Year Est. Return
+8.2%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$502M
AUM Growth
+$13.2M
(+2.7%)
Cap. Flow
+$34.7M
Cap. Flow
% of AUM
6.91%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
5
Increased
–
Reduced
1
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$7.44M |
| 2 |
Southwest Airlines
LUV
|
+$7.26M |
| 3 |
Blackrock
BLK
|
+$7.07M |
| 4 |
AIV
Aimco
AIV
|
+$6.86M |
| 5 |
DFS
Discover Financial Services
DFS
|
+$6.81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total World Stock ETF
VT
|
+$738K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 2.63% |
| 2 | Healthcare | 1.62% |
| 3 | Real Estate | 1.42% |
| 4 | Industrials | 1.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vanguard Total World Stock ETF
VT
$77.2B
| $467M | 92.93% |
6,634,100
-9,900
| -0.1% | -$738K |
|
|
2
Vertex Pharmaceuticals
VRTX
$122B
| $8.16M | 1.62% |
+48,000
| New | +$7.44M |
|
|
AIV
3
Aimco
AIV
$384M
| $7.12M | 1.42% |
+1,263,448
| New | +$6.86M |
|
|
4
Southwest Airlines
LUV
$23.6B
| $7.02M | 1.4% |
+137,900
| New | +$7.26M |
|
|
5
Blackrock
BLK
$163B
| $6.67M | 1.33% |
+13,370
| New | +$7.07M |
|
|
DFS
6
DELISTED
Discover Financial Services
DFS
| $6.53M | 1.3% |
+92,800
| New | +$6.81M |
|
Similar funds
CB
CW
LIC
SIM
HCM
BA
LC
HJA
Highland Associates's Q2 2018 Portfolio in Review
As of Q2 2018, Highland Associates held 6 positions worth $502M, up 2.7% from $489M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Highland Associates deployed $34.7M of net new capital in Q2 2018, opening 5 new positions. Its largest new stake was Vertex Pharmaceuticals: 48,000 shares worth $8.16M.
By sector, the portfolio is most concentrated in Financials at 2.6% of assets, followed by Healthcare and Real Estate.
On the sell side, the largest reduction was Vanguard Total World Stock ETF, an estimated $738K trimmed.
- Highland Associates's largest Q2 2018 buy was Vertex Pharmaceuticals: 48,000 shares worth $8.16M.
- Highland Associates's biggest Q2 2018 reduction was Vanguard Total World Stock ETF, cutting an estimated $738K.
- Highland Associates's ten largest holdings make up 100% of its $502M portfolio in Q2 2018.
- Highland Associates opened 5 new positions and closed 0 in Q2 2018.
- Highland Associates's portfolio value rose 2.7% quarter-over-quarter to $502M.
Based on Highland Associates's 13F filing for Q2 2018, filed 6 Aug 2018.